Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EICAR: Low Iodine Concentration in Coronary CTA
NCT02462044Phase 4Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Aug 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of iopromide in coronary artery disease (CAD) (3 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: Intravascular contrast enhancement. Started Aug 2014; status: completed.
02
Drugs
iopromide
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02462044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02462044.